Status:
COMPLETED
Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
Lead Sponsor:
Bayer
Conditions:
Postmenopause
Hypertension
Eligibility:
FEMALE
45-65 years
Phase:
PHASE2
Brief Summary
The main purpose of this study is to compare the effects of treatment of two different formulations of Angeliq® and Prempro on blood pressure in post-menopausal women with prehypertension.
Detailed Description
This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc. is the sponsor of the trial.
Eligibility Criteria
Inclusion
- \- Postmenopausal women 45 - 65 years old with prehypertension
Exclusion
- \- Hormone therapy (estrogen/progestin)
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT00420342
Start Date
January 1 2007
End Date
September 1 2008
Last Update
June 2 2015
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Greenbrae, California, United States, 94904
2
San Diego, California, United States, 92108
3
Daytona Beach, Florida, United States, 32114
4
Miami, Florida, United States, 33136